SNAI1 and cholangiocarcinoma: Previous studies have demonstrated that the activation of the NF-κB pathway blocked the degradation and promoted the transcription of Snail1 (62), subsequently facilitating the migration and invasion in breast, colorectal, gastric cancers, cholangiocarcinoma and malignant human keratinocyte (63–66).